No Data
No Data
Trevi Therapeutics Has Priced An Underwritten Offering Of 12.5M Shares At $4.00 Per Share, For Total Proceeds Of $50M
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD), Editas Medicine (EDIT) and Trevi Therapeutics (TRVI)
Trevi Therapeutics Announces Pricing of $50 Million Underwritten Offering
Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 38% Over Last Week
A Quick Look at Today's Ratings for Trevi Therapeutics(TRVI.US), With a Forecast Between $6 to $9
12 Health Care Stocks Moving In Thursday's Pre-Market Session